Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.600NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.525 (Eta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.525 (Eta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.7 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.7.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.7.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EU.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KB.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KB.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CJ.1.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CJ.1.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XANNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XANNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.132 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.132 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KF.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KF.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XCSNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCSNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.7.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.7.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.15.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used